Indocyanine Green Performance Enhanced System for Potent Photothermal Treatment of Bacterial Infection.

The instability in solution and aggregation-induced self-quenching of indocyanine green (ICG) have weakened its fluorescence and photothermal properties, thus inhibiting its application in practice. In this study, the cationic and anionic liposomes containing ICG were prepared based on 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-glycerol (DPPG), respectively. Molecular dynamics (MD) simulations demonstrate that ICG molecules are better distributed in the membranes of cationic DOTAP-based liposomes, leading to a superior fluorescence and photothermal performance. The liposomal ICG also shows the physical and photothermal stability during irradiation and long-term storage. On this basis, the prepared DOTAP-based liposomal ICG was encapsulated in the self-healing hydrogel formed by guar gum through the borate/diol interaction. The proposed liposomal ICG-loaded hydrogel can not only convert near-infrared (NIR) light into heat effectively but also repair itself without external assistance, which will realize potent photothermal therapy (PTT) against bacterial infection and provide the possibility for meeting the rapidly growing needs of modern medicine.

A novel drug delivery system -- Drug crystallization encapsulated liquid crystal emulsion.

Liquid crystals (LCs) are widely used for drug delivery due to their controlled and sustained drug release properties. In this paper, drug crystallization encapsulated liquid crystal emulsion, a novel drug delivery system, was proposed. The lamellar liquid crystals formed by hydrogenated lecithin, which are similar to the skin stratum corneum lipid structure, are adopted as the drug carrier to encapsulate non-steroidal anti-inflammatory drugs (NSAIDs). As the model drug, ketoprofen exists in the hydrophobic core of emulsion as a drug crystal when squalane is used as the oil phase. The microstructure, sustained drug release behaviors, physicochemical property and biocompatibility of the system were examined by polarized light microscopy, rheological measurements, differential scanning calorimetry, X-ray diffraction, small-angle X-ray scattering, in vitro release study, and in vitro cellular cytotoxicity assay. The results have shown that the novel system lowers the drug crystal melting point and improves the thermal stability of liquid crystal structure. Besides, the excellent biocompatibility and sustained release property through the additional dissolution step of drug crystal show its application potentials in the topical cosmeceuticals. The results will also be helpful for in-depth understanding of the physical state of encapsulated drug in the liquid crystal carrier systems.